ARCHIVES

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

House Members Express Support for Cancer Program

September 12, 1980

NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies

November 6, 1987

FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else”

September 5, 1980

In Brief: Junqueira Of Brazil Named Next UICC President, Murphy Gets Another Term as Secretary General

September 5, 1980

Army Breast Cancer Program Seeks Grants Applicants

May 17, 1996

Schmitt To Chair Senate Health Appropriations Subcommittee

January 2, 1981